LIST OF TABLES
TABLE 1 Global Oncology Biosimilar Market Share, By Types of Cancer, 2016-2026 ($Million)
TABLE 2 Breast Cancer Occlusion Biosimilar Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Colorectal Cancer Oncology Biosimilar Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Global Oncology Biosimilar Market Share, By Drug Type, 2016-2026 ($Million)
TABLE 5 Global Oncology Biosimilar Market By Region, 2016-2026 ($ Million)
TABLE 6 Global Oncology Biosimilar Market Share Value, 2016-2026 ($Million)
TABLE 7 America Oncology Biosimilar Market Share Value, By Country, 2016-2026 ($Million)
TABLE 8 America Oncology Biosimilar Market Share value, By Types of Cancer, 2016-2026 ($Million)
TABLE 9 America Oncology Biosimilar Market Share value, By Drug Type, 2016-2026 ($Million)
TABLE 10 U.S. Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 11 U.S. Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 12 Canada Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 13 Canada Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 14 Mexico Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 15 Mexico Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 16 Latin America Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 17 Latin America Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 18 Europe Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)
TABLE 19 Europe Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 20 Europe Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 21 Germany Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 22 Germany Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 23 France Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 24 France Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 25 UK Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 26 UK Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 27 Italy Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 28 Italy Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 29 Spain Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 30 Spain Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 31 Rest of Europe Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 32 Rest of Europe Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 33 Asia-Pacific Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)
TABLE 34 Asia-Pacific Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 35 Asia-Pacific Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 36 Japan Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 37 Japan Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 38 China Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 39 China Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 40 Australia Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 41 Australia Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 42 India Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 43 India Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 44 South Korea Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 45 South Korea Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 46 Rest of Asia-pacific Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 47 Rest of Asia-pacific Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 48 LAMEA Oncology Biosimilar Market share Value, By Country, 2016-2026 ($Million)
TABLE 49 LAMEA Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 50 LAMEA Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 51 Saudi Arabia Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 52 Saudi Arabia Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 53 South Africa Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 54 South Africa Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 55 Brazil Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 56 Brazil Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
TABLE 57 Rest of LAMEA Oncology Biosimilar Market share, By Types of Cancer, 2016-2026 ($Million)
TABLE 58 Rest of LAMEA Oncology Biosimilar Market share, By Drug Type, 2016-2026 ($Million)
LIST OF FIGURES
FIGURE 1 Global Oncology Biosimilar Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Oncology Biosimilar Market, Market Share Analysis, 2018
FIGURE 9 Global Oncology Biosimilar Market, 2016-2026
FIGURE 10 U.S. Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 11 Canada Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 12 Mexico Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 13 Germany Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 14 France Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 15 UK Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 16 Italy Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 17 Spain Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 18 Rest of Europe Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 19 Japan Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 20 China Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 21 Australia Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 22 India Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 23 South Korea Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 24 Rest of Asia-pacific Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 25 Saudi Arabia Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 26 South Africa Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 27 Brazil Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 28 Rest of LAMEA Oncology Biosimilar Market share, 2016-2026 ($Million)
FIGURE 29 Teva Pharmaceutical Industries Ltd.: Revenue Analysis, ($ million)
FIGURE 30 Teva Pharmaceutical Industries Ltd.: Segment Revenue 2017 (%)
